Novel discovery could lead to new cancer, autoimmune disease therapy
International research project co-led by UBC Canada 150 Research Chair.
Rare but recurring mutations discovered in ER-positive breast cancer
The uncommon mutations were associated with early relapse and death, and thus stand out as therapeutic targets.
UBC bestows national prizes on Canadian health science pioneers
Andrew Krahn, Bruce McManus, Kullervo Hynynen and Martin Gleave are being honoured for their accomplishments in heart health, brain health and cancer.
HPV test better than Pap test at detecting cervical precancer
A study of 19,000 women in British Columbia showed that the HPV test finds precancer sooner.
“Arms race” between cancer and immune system revealed
The study led by MD/PhD student Allen Zhang will assist the design of new immunotherapy trials.
UBC leads Canadian pancreatic cancer research initiative
The $5 million project will sequence metastatic pancreatic tumours of 400 patients, looking to see if the primary cancers genetically differ from metastatic cancers.
An under-the-radar immune cell shows potential in fight against cancer
ILC2 cells were discovered as a major player in asthma. Wilf Jefferies found they may also stop cancer from metastasizing.
Do men’s toenails contain clues about prostate cancer prevention?
Researchers will analyze concentrations of toxic metals and look for correlations with the histories of prostate cancer patients.
An unexpected target — and weapon — for one of the deadliest cancers
A new drug, fostamatinib, reduced the growth rate of esophageal adenocarcinoma in mice by at least 70 per cent.
UBC Medicine receives 40% of national genomics funding
The 10 projects, totaling $101 million, include an effort to reduce the risk of kidney transplant rejection.